Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

Osteoporosis International

Volumn 21, Issue 8, 2010, Pages 1401-1409

  Chang, I C ^a,b   Chiang, T I ^a,b   Yeh, K T ^a,c   Lee, H ^a   Cheng, Y W ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Bone mineral density; Estrogen; Osteopontin (OPN); Postmenopausal osteoporosis

Indexed keywords

OSTEOPONTIN;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CONCENTRATION (PARAMETERS); DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; MOUSE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALKALINE PHOSPHATASE; BONE DENSITY; BONE RESORPTION; CASE-CONTROL STUDIES; COLLAGEN TYPE I; EARLY DIAGNOSIS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPONTIN; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; RISK FACTORS;

EID: 77954531706     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1107-7     Document Type: Article

References (47)

1. M Ishijima Y Ezura T Kunikazu SR Rittling H Kurosawa DT Denhardt M Emi A Nifuji M Noda 2006 Osteopontin during tail-suspension-induced bone loss Exp Cell Res 312 3075 3083 10.1016/j.yexcr.2006.06.003 1:CAS:528:DC%2BD28XptFSqtbc%3D 16889770 (Pubitemid 44292660)
2. SR Rittling HN Matsumoto MD Mckee A Nanci XR An KE Novick AJ Kowalski M Noda DT Denhardt 1998 Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro J Bone Miner Res 13 1101 1111 10.1359/jbmr.1998.13.7.1101 1:CAS:528:DyaK1cXks1arsr8%3D 9661074 (Pubitemid 28311778)
3. SR Rittling DT Denhardt 1999 Osteopontin function in pathology: lessons from osteopontin-deficient mice Exp Nephrol 7 103 113 10.1159/000020591 1:CAS:528:DyaK1MXjtVSju7k%3D 10213864
4. H Yoshitake SR Rittling DT Denhardt M Noda 1999 Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption Proc Natl Acad Sci U S A 96 8156 8160 10.1073/pnas.96.14.8156 1:CAS:528:DyaK1MXltVOrsL8%3D 10393964 (Pubitemid 29328424)
5. Y Asou SR Rittling H Yoshitake K Tsuji K Shinomiya A Nifuji DT Denhardt M Noda 2001 Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone Endocrinology 142 1325 1332 10.1210/en.142.3.1325 1:CAS:528:DC%2BD3MXhsFemtbg%3D 11181551 (Pubitemid 32202845)
6. H Ihara DT Denhardt K Furuya T Yamashita Y Muguruma K Tsuji KA Hruska K Higashio S Enomoto A Nifuji SR Rittling M Noda 2001 Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin J Biol Chem 276 13065 13071 10.1074/jbc.M010938200 1:CAS:528:DC%2BD3MXjtFyms7c%3D 11278791
7. K Yumoto M Ishijima SR Rittling K Tsuji Y Tsuchiya S Kon A Nifuji T Uede DT Denhardt M Noda 2002 Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice Proc Natl Acad Sci U S A 99 4556 4561 10.1073/pnas.052523599 1:CAS:528: DC%2BD38XivFShurk%3D 11930008 (Pubitemid 34286023)
8. M Morinobu M Ishijima SR Rittling K Tsuji H Yamamoto A Nifuji DT Denhardt M Noda 2003 Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo J Bone Miner Res 18 1706 1715 10.1359/jbmr.2003.18.9.1706 1:CAS:528:DC%2BD3sXnsVymu7k%3D 12968681 (Pubitemid 37022930)
9. K Kitahara M Ishijima SR Rittling K Tsuji H Kurosawa A Nifuji DT Denhardt M Noda 2003 Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation Endocrinology 144 2132 2140 10.1210/en.2002-220996 1:CAS:528:DC%2BD3sXjt1Wit7o%3D 12697722 (Pubitemid 36543353)
10. Y Chen BS Bal JP Gorski 1992 Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone J Biol Chem 267 24871 24878 1:CAS:528:DyaK38XmtVOntLk%3D 1447223
11. JR Hoyer L Otvos Jr L Urge 1995 Osteopontin in urinary stone formation Ann N Y Acad Sci 760 257 265 10.1111/j.1749-6632.1995.tb44636.x 1:CAS:528:DyaK2MXovVSitrc%3D 7785900
12. RL MacNeli J Berry SC D'ErricoJ B Piotrowski MJ Somerman 1995 Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis Connect Tissue Res 33 1 7 10.3109/03008209509016974
13. MA Horton MA Nesbit MH Helfrich 1995 Interaction of osteopontin with osteoclast integrins Ann N Y Acad Sci 760 190 200 10.1111/j.1749-6632.1995. tb44630.x 1:CAS:528:DyaK2MXovVSitr0%3D 7540373
14. CM Giachelli L Liaw CE Murry S Schwartz MM Almeida 1995 Osteopontin expression in cardiovascular diseases Ann N Y Acad Sci 760 109 126 10.1111/j.1749-6632.1995.tb44624.x 1:CAS:528:DyaK2MXovVSisbk%3D 7785890
15. L Liaw DM Lombardi MM Almeida SM Schwartz D DeBlois CM Giachelli 1997 Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation Arterioscler Thromb Vasc Biol 17 188 193 1:CAS:528:DyaK2sXhtFGmsr0%3D 9012655
16. R Pichler CM Giachelli B Young CE Alpers WG Couser RJ Johnson 1995 The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory Miner Electrolyte Metab 21 317 327 1:CAS:528:DyaK2MXntlChtLg%3D 7565480
17. DR Senger LF Brown CA Perruzzi A Papadopoulos-Sergiou L Van de Water 1995 Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion Ann N Y Acad Sci 760 83 100 10.1111/j.1749-6632.1995.tb44622.x 1:CAS:528:DyaK2MXovVSisbs%3D 7540380
18. GF Weber S Ashkar MJ Glimcher H Cantor 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1) Science 271 509 512 10.1126/science.271. 5248.509 1:CAS:528:DyaK28XmvFyrtA%3D%3D 8560266
19. OD Kennedy O Brennan SM Rackard A Staines FJ O'Brien D Taylor TC Lee 2009 Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery J Orthop Res 27 303 309 10.1002/jor.20750 18853433
20. SA Shapses M Cifuentes L Spevak H Chowdhury J Brittingham AL Boskey DT Denhardt 2003 Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency Calcif Tissue Int 73 1 86 92 10.1007/s00223-002-1090-x 1:CAS:528:DC%2BD3sXmsFGltbg%3D 14506959 (Pubitemid 37022084)
21. M Ishijima K Tsuji SR Rittling T Yamashita H Kurosawa DT Denhardt A Nifuji Y Ezura M Noda 2007 Osteopontin is required for mechanical stress-dependent signals to bone marrow cells J Endocrinol 193 2 235 243 10.1677/joe.1.06704 1:CAS:528:DC%2BD2sXlvFKkur0%3D 17470514
22. NB Kavukcuoglu DT Denhardt N Guzelsu AB Mann 2007 Osteopontin deficiency and aging on nanomechanics of mouse bone J Biomed Mater Res 83 1 136 144 10.1002/jbm.a.31081 (Pubitemid 47435658)
23. RM McCann G Colleary C Geddis SA Clarke GR Jordan GR Dickson D Marsh 2008 Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model J Orthop Res 26 384 393 10.1002/jor.20505 17960650
24. L Malaval NM Wade-Guéye M Boudiffa J Fei R Zirngibl F Chen N Laroche JP Roux B Burt-Pichat F Duboeuf G Boivin P Jurdic MH Lafage-Proust J Amédée L Vico J Rossant JE Aubin 2008 Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis J Exp Med 205 5 1145 1153 10.1084/jem.20071294 1:CAS:528:DC%2BD1cXlvFWrs7g%3D 18458111 (Pubitemid 351679689)
25. DT Denhardt M Noda 1998 Osteopontin expression and function: role in bone remodeling J Cell Biochem Suppl 31 92 102 10.1002/(SICI)1097-4644(1998)72:30/ 31+<92::AID-JCB13>3.0.CO;2-A
26. ST Choi JH Kim EJ Kang SW Lee MC Park YB Park SK Lee 2008 Osteopontin might be involved in bone remodeling rather than in inflammation in ankylosing spondylitis Rheumatology 47 1775 1779 10.1093/rheumatology/ken385 1:CAS:528:DC%2BD1cXhtl2gsrbJ 18854347
27. QT Le PD Sutphin S Raychaudhuri SC Yu DJ Terris HS Lin B Lum HA Pinto AC Koong AJ Giaccia 2003 Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Clin Cancer Res 9 1 59 67 1:CAS:528:DC%2BD3sXnt1yitg%3D%3D 12538452
28. J Overgaard JG Eriksen M Nordsmark J Alsner MR Horsman Danish Head and Neck Cancer Study Group 2005 Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer Lancet Oncol 6 757 764 10.1016/S1470-2045(05)70292-8 1:CAS:528:DC%2BD2MXhtVGrs73F 16198981 (Pubitemid 41430716)
29. D Vordermark HM Said A Katzer T Kuhnt G Hansgen J Dunst M Flentije M Bache 2006 Plasma osteopontin lecels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system BMC Cancer 207 1 6
30. Eastell R (2003) Pathogenesis of postmenopausal osteoporosis. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington (DC), pp 314-316
31. R Recker J Lappe K Davies R Heaney 2000 Characterization of perimenopausal bone loss: a prospective study J Bone Miner Res 15 1965 1973 10.1359/jbmr.2000.15.10.1965 1:STN:280:DC%2BD3cvnslSkuw%3D%3D 11028449
32. B Abrahamsen N Nissen AP Hermann B Hansen O Bärenholdt P Vestergaard CL Tofteng S Pors Nielsen 2002 When should densitometry be repeated in healthy peri- and postmenopausal women? The Danish osteoporosis prevention study J Bone Miner Res 17 2061 2067 10.1359/jbmr.2002.17.11.2061 1:STN:280: DC%2BD38nltFGmtA%3D%3D 12412814
33. Y Li A Li X Yang MN Weitzmann 2007 Ovariectomy-induced bone loss occurs independently of B cells J Cell Biochem 100 6 1370 1375 10.1002/jcb.21121 1:CAS:528:DC%2BD2sXjvVSlsbc%3D 17131364 (Pubitemid 46515571)
34. K Suzuki B Zhu SR Rittling DT Denhardt HA Goldberg CA McCulloch J Sodek 2002 Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts J Bone Miner Res 17 8 1486 1497 10.1359/jbmr.2002.17.8.1486 1:CAS:528:DC%2BD38XmsVWktbo%3D 12162503
35. RM Rajachar AQ Truong CM Giachelli 2008 The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts J Mater Sci Mater Med 19 10 3279 3285 10.1007/s10856-008-3455-9 1:CAS:528:DC%2BD1cXhtVSktbbL 18483788
36. N Ono K Nakashima SR Rittling E Schipani T Hayata K Soma DT Denhardt HM Kronenberg Y Ezura M Noda 2008 Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts J Biol Chem 283 28 19400 19409 10.1074/jbc.M800005200 1:CAS:528:DC%2BD1cXotF2ksL0%3D 18417476
37. H Namkung-Matthai R Appleyard J Jansen 2001 Osteoporosis influences the early period of fracture healing in a rat osteoporotic model Bone 28 80 86 10.1016/S8756-3282(00)00414-2 1:STN:280:DC%2BD3MzitFKjtA%3D%3D 11165946 (Pubitemid 32112065)
38. M Roseleen GC McCann C Geddis SA Clarke GR Jordan GR Dickson D Marsh 2008 Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model J Orthop Res 26 384 393 10.1002/jor.20505
39. M D'Amore M Fanelli S D'Amore A Fontana G Minenna 2006 Receptor activator of NF (Kappa) B ligand/osteoprotegerin (RANKL/OPG) system and osteoportnin (OPN) serum levels in a population of apullian postmenopausal women Panminerva Med 48 4 215 221 17215793
40. SF Vondracek LB Hansen MT McDermott 2009 Osteoporosis risk in premenopausal women Pharmacotherapy 29 3 305 317 10.1592/phco.29.3.305 19249949
41. L Bischoff CT Derk 2008 Premenopausal osteoporosis Minerva Med 99 1 55 63 1:STN:280:DC%2BD1c7ktVKntQ%3D%3D 18299696
42. ME Hamel RJ Sebaldt K Siminoski JD Adachi AP Papadimitropoulos CH Goldsmith 2005 Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers Osteoporos Int 16 208 215 10.1007/s00198-004-1776-1 15517185 (Pubitemid 40193210)
43. DH Solomon E Levin SM Helfgott 2000 Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment J Rheumatol 27 1496 1500 1:STN:280:DC%2BD3cvotlGhsg%3D%3D 10852277
44. A Pressman B Forsyth B Ettinger ANA Tosteson 2001 Initiation of osteoporosis treatment after bone mineral density testing Osteoporos Int 12 337 342 10.1007/s001980170099 1:STN:280:DC%2BD3MzovF2hsA%3D%3D 11444079 (Pubitemid 32606455)
45. EE Hajcsar G Hawker ER Bogoch 2000 Investigation and treatment of osteoporosis in patients with fragility fractures Can Med Assoc J 163 819 822 1:STN:280:DC%2BD3cvos1Sgtg%3D%3D
46. R Ridout GA Hawker 2000 Use of bone densitometry by Ontario family physicians Osteoporos Int 11 393 399 10.1007/s001980070105 1:STN:280: DC%2BD3cvgvFeltQ%3D%3D 10912840 (Pubitemid 30450121)
47. LJ Papa BE Weber 1997 Physician characteristics associated with the use of bone densitometry J Gen Intern Med 12 781 783 10.1046/j.1525-1497.1997.07165. x 1:STN:280:DyaK1c%2Fpslequw%3D%3D 9436899 (Pubitemid 28012128)